Unlock stock picks and a broker-level newsfeed that powers Wall Street.
OTC Markets OTCQB - Delayed Quote USD

FLUENT Corp. (CNTMF)

Compare
0.0595
-0.0010
(-1.65%)
At close: 1:57:12 PM EDT
Loading Chart for CNTMF
  • Previous Close 0.0605
  • Open 0.0595
  • Bid 0.0594 x --
  • Ask 0.0600 x --
  • Day's Range 0.0595 - 0.0595
  • 52 Week Range 0.0500 - 0.2500
  • Volume 8,500
  • Avg. Volume 219,655
  • Market Cap (intraday) 33.827M
  • Beta (5Y Monthly) 2.91
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0700
  • Earnings Date Apr 28, 2025 - May 2, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

FLUENT Corp., through its subsidiaries, produces and sells medical cannabis in Florida, Pennsylvania, and Texas. The company's medical cannabis products are offered in oral drops, capsules, topicals, syringes, dried flower, pre-rolls, cartridges, concentrates, and edibles under the Fluent brand name. It also sells various third-party branded medical cannabis products. The company was formerly known as Cansortium Inc. and changed its name to FLUENT Corp. in February 2025. FLUENT Corp. was incorporated in 2018 and is headquartered in Tampa, Florida.

getfluent.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CNTMF

View More

Performance Overview: CNTMF

Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

CNTMF
12.50%
S&P/TSX Composite index (^GSPTSE)
2.79%

1-Year Return

CNTMF
75.21%
S&P/TSX Composite index (^GSPTSE)
14.64%

3-Year Return

CNTMF
84.34%
S&P/TSX Composite index (^GSPTSE)
15.28%

5-Year Return

CNTMF
93.50%
S&P/TSX Composite index (^GSPTSE)
93.22%

Compare To: CNTMF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CNTMF

View More

Valuation Measures

Annual
As of 4/1/2025
  • Market Cap

    34.40M

  • Enterprise Value

    138.97M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.20

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    1.33

  • Enterprise Value/EBITDA

    3.59

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -18.92%

  • Return on Assets (ttm)

    5.23%

  • Return on Equity (ttm)

    -534.24%

  • Revenue (ttm)

    104.19M

  • Net Income Avi to Common (ttm)

    -19.71M

  • Diluted EPS (ttm)

    -0.0700

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    8.93M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -41.7M

Research Analysis: CNTMF

View More

Company Insights: CNTMF

Research Reports: CNTMF

View More

People Also Watch